1. Zhao, Wei, Yao, Mengyu, Zhang, Yunyi, Cao, Yu, Li, Hongrong. 2022. Endothelial cyclin I reduces vulnerability to angiotensin II-induced vascular remodeling and abdominal aortic aneurysm risk. In Microvascular research, 142, 104348. doi:10.1016/j.mvr.2022.104348. https://pubmed.ncbi.nlm.nih.gov/35245516/
2. Quandt, Eva, Masip, Núria, Hernández-Ortega, Sara, Clotet, Josep, Ribeiro, Mariana P C. 2023. CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferation. In Molecular oncology, 17, 1228-1245. doi:10.1002/1878-0261.13438. https://pubmed.ncbi.nlm.nih.gov/37081792/
3. Bian, Weikang, Wang, Zhicheng, Li, Xiaobo, Liu, Zhizhong, Zhang, Dai-Min. 2022. Identification of vital modules and genes associated with heart failure based on weighted gene coexpression network analysis. In ESC heart failure, 9, 1370-1379. doi:10.1002/ehf2.13827. https://pubmed.ncbi.nlm.nih.gov/35128826/
4. Cybulski, Marek, Jeleniewicz, Witold, Nowakowski, Andrzej, Kotarski, Jan, Stepulak, Andrzej. . Cyclin I mRNA expression correlates with kinase insert domain receptor expression in human epithelial ovarian cancer. In Anticancer research, 35, 1115-9. doi:. https://pubmed.ncbi.nlm.nih.gov/25667501/
5. Deng, Y J, Huang, Z X, Zhou, C J, Zhong, B Y, Hao, F. 2005. Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus. In Molecular immunology, 43, 1497-507. doi:. https://pubmed.ncbi.nlm.nih.gov/16143398/